Relation between rhinosinusitis and bronchiectasis;Relaciones entre rinosinusitis y bronquiectasias

Archivos de Bronconeumologia

Volumn 42, Issue 3, 2006, Pages 135-140

  Guilemany, J M ^a,b   Mullol, J ^a   Picado, C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Bronchiectasis; Rhinitis; Sinusitis

Indexed keywords

ALPHA 1 ANTITRYPSIN DEFICIENCY; BRONCHIECTASIS; BRONCHITIS; CILIARY DYSKINESIA; COMPUTER ASSISTED TOMOGRAPHY; COR PULMONALE; CYSTIC FIBROSIS; HAEMOPHILUS INFLUENZAE; HUMAN; MUCOCILIARY TRANSPORT; PSEUDOMONAS; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; REVIEW; RHINOSINUSITIS; SYNDROME; YOUNG SYNDROME;

EID: 33645835957     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13085563     Document Type: Review

References (53)

1. Simons FE. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol. 1999;104:534-40.
2. Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenberge P, Bousquet J. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin Am. 2004;24:19-43.
3. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:S147-334.
4. Proctor DF. The upper airways. Nasal physiology and defense of the lungs. Am Rev Respir Dis. 1977;115:97-119.
5. Zhao K, Scherer PW, Hajiloo SA, Dalton P. Effect of anatomy on human nasal air flow and odorant transport patterns: implications for olfaction. Chem Senses. 2004;29:365-79.
6. Gaga M, Vignola AM, Chánez P. Upper and lower airways: similarities and differences. En: Wallaërt B, Chánez P, Godard P, editors. The nose and lung diseases. Eur Respir Mon. 2001;6 Mon 18:10-5.
7. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989;11;1:520-4.
8. Martínez-Hernandez A, Amenta PS. The basement membrane in pathology. Lab Invest. 1983;48:656-77.
9. Chánez P, Vignola AM, Vic P, Guddo F, Bonsignore G, Godard P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med. 1999;159:588-95.
10. Rutland J, Griffin WM, Cole PJ. Human ciliary beat frequency in epithelium from intrathoracic and extrathoracic airways. Am Rev Respir Dis. 1982;125:100-5.
11. Owen CA, Campbell EJ, Hill SL, Stockley RA. Increased adherence of monocytes to fibronectin in bronchiectasis. Am Rev Respir Dis. 1992;146:626-31.
12. Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol. 2000;106:201-5.
13. Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis. A review of 6,037 patients. J Allergy Clin Immunol. 1977;59:17-21.
14. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest. 2000;117:1S-4S.
15. Vachier I, Vignola AM, Chiappara G, Bruno A, Meziane H, Godard P, et al. Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax. 2004;59:303-7.
16. Roberts NJ, Lloyd-Owen SJ, Rapado F, Patel IS, Wilkinson TM, Donaldson GC, et al. Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respir Med. 2003;97:909-14.
17. Angrill J, Agustí C, Torres A. Bronchiectasis. Curr Opin Infect Dis. 2001;14:193-7.
18. Laennec RTH. A treatise on the disease of the chest. New York: Library of the New York Academy of Medicine, Hafner Publishing; 1962. p. 78.
19. Reid LM. Reduction in bronchial subdivision in bronchiectasis. Thorax. 1950;5:233-47.
20. Cole PJ. Inflammation: a two-edged sword -the model of bronchiectasis. Eur J Respir Dis Suppl. 1986;147:6-15.
21. Gaga M, Bentley AM, Humbert M, Barkans J, O'Brien F, Wathen CG, et al. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax. 1998;53:685-91.
22. Limper AH, Prakash UB. Tracheobronchial foreign bodies in adults. Ann Intern Med. 1990;15:604-9.
23. Tsang KW, Chan K, Ho P, Zheng L, Ooi GC, Ho JC, et al. Sputum elastase in steady-state bronchiectasis. Chest. 2000;117:420-6.
24. Richman-Eisenstat JB, Jorens PG, Hebert CA, Ueki I, Nadel JA. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol. 1993;264:L413-8.
25. Shum DK, Chan SC, Ip MS. Neutrophil-mediated degradation of lung proteoglycans: stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162:1925-31.
26. Tamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, Takizawa T. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis. 1992;145:548-52.
27. Angrill J, Agustí C, De Celis R, Rano A, González J, Solé T, et al. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax. 2002;57:15-9.
28. Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest. 1995;108:955-61.
29. Barker AF. Bronchiectasis. N Engl J Med. 2002;346:1383-93.
30. Hansell DM. Bronchiectasis. Radiol Clin North Am. 1998;36:107-28.
31. Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:400-7.
32. Keistinen T, Saynajakangas O, Tuuponen T, Kivela SL. Bronchiectasis: an orphan disease with a poorly understood prognosis. Eur Respir J. 1997;10:2784-7.
33. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989;245:1059-65.
34. Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science. 1992;256:774-9.
35. Gilljam M, Ellis L, Corey M, Zielenski J, Durie P, Tullis DE. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest. 2004;126:1215-24.
36. Wood B. Cystic fibrosis: 1997. Radiology. 1977;204:1-10.
37. Yung MW, Gould J, Upton GJ. Nasal polyposis in children with cystic fibrosis: a long-term follow-up study. Ann Otol Rhinol Laryngol. 2002;111:1081-6.
38. Wang L, Freedman SD. Laboratory tests for the diagnosis of cystic fibrosis. Am J Clin Pathol. 2002;117:109-15.
39. Salcedo A, Girón RM, Beltrán B, Martínez A, Máiz L, Suárez L; Fundación Sira Carrasco. Conferencia de consenso. Tratamiento antibiótico intravenoso domiciliario en la fibrosis quística; 2002, abril 26. Arch Bronconeumol. 2003;39:469-75.
40. Bush A, O'Callaghan C. Primary ciliary dyskinesia. Arch Dis Child. 2002;87:363-5.
41. Coren ME, Meeks M, Morrison I, Buchdahl RM, Bush A. Primary ciliary dyskinesia: age at diagnosis and symptom history. Acta Paediatr. 2002;91:667-9.
42. Chin GY, Karas DE, Kashgarian M. Correlation of presentation and pathologic condition in primary ciliary dyskinesia. Arch Otolaryngol Head Neck Surg. 2002;128:1292-4.
43. Armengot M, Carda C, Escribano A, Samper GJ. Estudio del transporte mucociliar y de la ultraestructura ciliar nasales en pacientes con síndrome de Kartagener. Arch Bronconeumol. 2005;41:11-5.
44. Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha M, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med. 2004;169:459-67.
45. Corbelli R, Bringolf-Isler B, Amacher A, Sasse B, Spycher M, Hammer J. Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia. Chest. 2004;126:1054-9.
46. Domingo C, Mirapeix RM, Encabo B, Roig J, López D, Ruiz J. Hallazgos clínicos y ultraestructura de la discinesia ciliar primaria y el síndrome de Young. Rev Clin Esp. 1997;197:100-3.
47. Handelsman DJ, Conway AJ, Boylan LM, Turtle JR. Young's syndrome: Obstructive azoospermia and chronic sinopulmonary infections. N Engl J Med. 1984;310:3-9.
48. Tomashefski JF Jr, Crystal RG, Wiedemann HP, Mascha E, Stoller JK; Alpha 1-Antitrypsin Deficiency Registry Study Group. The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the national registry for individuals with Severe Deficiency of Alpha-1 Antitrypsin. Hum Pathol. 2004;35:1452-61.
49. Hutchison DC, Cooper D; British Thoracic Society. Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials. Respir Med. 2002;96:872-80.
50. Lomas DA, Parfrey H. Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. Thorax. 2004;59:529-35.
51. De la Roza C, Costa X, Vidal R, Vila S, Rodríguez-Frías F, Jardí R, et al. Programa de cribado para el déficit α 1-antitripsina en pacientes con EPOC mediante el uso de gota de sangre en papel secante. Arch Bronconeumol. 2003;39:8-12.
52. Strange C, Dickson R, Carter C, Carpenter MJ, Holladay B, Lundquist R, et al. Genetic testing for alpha1-antitrypsin deficiency. Genet Med. 2004;6:204-10.
53. American Thoracic Society/European Respiratory Society Statement. Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168:818-900.